ArticleInvestigational new drugs2021

Rapamycin synergizes the cytotoxic effects of MEK inhibitor binimetinib and overcomes acquired resistance to therapy in melanoma cell lines in vitro.

Oxana O Ryabaya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.